Concord Drugs standalone net profit rises 108.33% in the September 2015 quarter

Sales rise 22.33% to Rs 11.89 crore

Net profit of Concord Drugs rose 108.33% to Rs 0.25 crore in the quarter ended September 2015 as against Rs 0.12 crore during the previous quarter ended September 2014. Sales rose 22.33% to Rs 11.89 crore in the quarter ended September 2015 as against Rs 9.72 crore during the previous quarter ended September 2014. ParticularsQuarter EndedSep. 2015Sep. 2014% Var.Sales11.899.72 22 OPM %14.6314.40 -PBDT1.120.82 37 PBT0.360.15 140 NP0.250.12 108

Powered by Capital Market - Live News